Published in
Springer, Clinical and Translational Oncology, 6(22), p. 844-851, 2019
DOI: 10.1007/s12094-019-02193-w
Links
Tools
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes
Journal article published in 2019 by
A. Cortellini 
,
A. Leonetti,
A. Catino,
P. Pizzutillo,
B. Ricciuti,
A. De Giglio,
R. Chiari ,
P. Bordi,
D. Santini,
R. Giusti,
M. De Tursi,
D. Brocco,
F. Zoratto,
F. Rastelli,
F. Citarella
and other authors.
,
A. Leonetti,
A. Catino,
P. Pizzutillo,
B. Ricciuti,
A. De Giglio,
R. Chiari ,
P. Bordi,
D. Santini,
R. Giusti,
M. De Tursi,
D. Brocco,
F. Zoratto,
F. Rastelli,
F. Citarella
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 